Evaluation of Chlorhexidine Plus Hyaluronic Acid Mouthwash in Surgical Wound Healing Following Third Molar Surgery (CLOR_4)
Launched by UNIVERSITY OF PISA · Jun 7, 2022
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial, called CLOR_4, is studying how well a special mouthwash containing chlorhexidine and hyaluronic acid helps healing after third molar surgery, which is commonly known as wisdom tooth removal. The researchers want to see if this mouthwash can improve the recovery of the gum tissues following the surgery.
To participate, you need to be a healthy adult between 18 and 70 years old who is scheduled for third molar surgery and willing to follow the study's guidelines. However, if you are pregnant, breastfeeding, or have certain health conditions, you may not be eligible. If you join the study, you can expect to use the mouthwash as directed and attend follow-up visits to monitor your healing process. This trial is currently recruiting participants, and it aims to find out if the mouthwash can make a difference in recovery after surgery.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • males or females of age range between 18 and 70 years,
- • good health status,
- • indication to perform third molar surgery,
- • patients willing to give informed consent,
- • compliance to the study follow-up,
- Exclusion Criteria:
- • pregnancy or breast-feeding,
- • indication to antibiotic therapy prior to surgical treatment,
- • chronic infections,
- • systemic diseases (including cardiovascular, pulmonary, cerebral, and metabolic diseases),
- • previous therapy with the mouth rinses employed in the present study, and
- • smoking habit (\>20 cigarettes per day, and/or pipe or cigar smoking).
About University Of Pisa
The University of Pisa is a prestigious academic institution renowned for its commitment to advancing scientific research and education. With a rich history dating back to the 12th century, the university is dedicated to fostering innovation and excellence in various fields, including medicine and health sciences. As a clinical trial sponsor, the University of Pisa leverages its robust research infrastructure and interdisciplinary expertise to conduct rigorous clinical studies aimed at improving patient outcomes and contributing to the body of medical knowledge. Its collaborative approach involves partnerships with healthcare institutions and industry stakeholders, ensuring that research is aligned with the highest ethical standards and regulatory compliance.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Pisa, , Italy
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials